DESIGNED TO BE THE MOST DELIVERABLE TAVI VALVE
Aortic valve stenosis has been reported to be the most common valve abnormality.1 And when your patients present with aortic stenosis, the only definitive treatment is aortic heart valve replacement.2
Replacement can be achieved surgically or with transcatheter aortic valve implantation (TAVI).
Abbott’s dedication to offering optimal treatment—through the minimally invasive TAVI procedure—is apparent in the advantages that characterize its TAVI valve, Portico.
Chief among the advantages: Portico offers the lowest profile**, now with a sheathless indication.3,4
Portico is the first resheathable, self-expanding valve on the market*